Consolidated Statements Of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income	$ 698,029	$ 1,360,040
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	224,381	178,162
Earnings of equity method investments, net of distributions	3,184	169
Loss on Extinguishment of Debt Due to Unamortized Discount	(7,948)	0
Gain (Loss) on Sale of Investments	0	(326)
Deferred income taxes	47,053	22,728
Equity based compensation expense	25,239	25,399
Change in fair value - derivative instruments	(39,745)	(10,977)
(Increase) decrease in current assets:
Accounts receivable	(110,402)	(29,474)
Inventories	(228,541)	(370,831)
Income taxes receivable	670	53,465
Prepayments and other	18,983	16,690
Increase (decrease) in current liabilities:
Accounts payable	298,916	(96,263)
Income taxes payable	0	110,533
Accrued liabilities	(7,888)	(6,166)
Turnaround expenditures	(170,468)	(74,612)
Other, net	34,804	(6,749)
Net cash provided by operating activities	802,163	1,171,788
Cash flows from investing activities:
Additions to properties, plants and equipment	(255,090)	(178,235)
Acquisition of trucking operations	(11,301)	0
Proceeds from Sale of Property, Plant, and Equipment	5,802	0
Investment in Sabine Biofuels	(3,000)	(2,000)
Advances to uncconsolidated subsidiary	(11,040)	0
Purchases of marketable securities	(672,701)	(236,315)
Sales and maturities of marketable securities	(646,301)	(212,216)
Net cash used for investing activities	(332,128)	(233,636)
Cash flows from financing activities:
Principal tender on senior notes	(286,812)	(205,000)
Redemption premium on early extinguishment of debt	(14,161)	0
Proceeds from sale of HEP common units	73,444	0
Proceeds from sale of HEP common units	73,444
Purchase of treasury stock	(184,947)	(190,307)
Structured stock repurchase arrangement	0	8,620
Contribution from joint venture partner	0	6,000
Dividends	(485,411)	(382,610)
Excess tax benefit from equity based compensation	2,739	16,021
Other	668	(4,454)
Net cash used for financing activities	(933,250)	(459,648)
Cash and cash equivalents:
Increase for the period	(463,215)	478,504
Beginning of period	1,757,699	1,578,904
End of period	1,294,484	2,057,408
Cash paid during the period for:
Interest	67,822	77,184
Income taxes	336,588	622,314
HEP [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	48,410	38,683
Cash flows from investing activities:
Additions to properties, plants and equipment	(31,099)	(29,302)
Proceeds from Sale of Property, Plant, and Equipment	5,802
Cash flows from financing activities:
Borrowings under credit agreement - HEP	256,500	523,000
Repayments under credit agreement - HEP	(312,500)	(292,000)
Net proceeds from issuance of senior notes - HEP	0	294,750
Principal tender on senior notes	0	(185,000)
Proceeds from sale of HEP common units		0
Proceeds from Common Unit Offering HEP	146,888
Distributions to noncontrolling interest	(52,835)	(43,749)
Purchase of units for incentive grants - HEP	(3,379)	(4,919)
Cash and cash equivalents:
Beginning of period	5,237
End of period	$ 11,220